DCA Protects against Oxidation Injury Attributed to Cerebral Ischemia-Reperfusion by Regulating Glycolysis through PDK2-PDH-Nrf2 Axis

Cerebral ischemic stroke (IS) is still a difficult problem to be solved; energy metabolism failure is one of the main factors causing mitochondrion dysfunction and oxidation stress damage within the pathogenesis of cerebral ischemia, which produces considerable reactive oxygen species (ROS) and open...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiaoyong Zhao, Shan Li, Yunchang Mo, Ruru Li, Shaoyi Huang, Anqi Zhang, Xuqing Ni, Qinxue Dai, Junlu Wang
Formato: article
Lenguaje:EN
Publicado: Hindawi Limited 2021
Materias:
Acceso en línea:https://doaj.org/article/51f6dbe5bcbb4bb4b9e1225bc3d78e3e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:51f6dbe5bcbb4bb4b9e1225bc3d78e3e
record_format dspace
spelling oai:doaj.org-article:51f6dbe5bcbb4bb4b9e1225bc3d78e3e2021-11-08T02:36:55ZDCA Protects against Oxidation Injury Attributed to Cerebral Ischemia-Reperfusion by Regulating Glycolysis through PDK2-PDH-Nrf2 Axis1942-099410.1155/2021/5173035https://doaj.org/article/51f6dbe5bcbb4bb4b9e1225bc3d78e3e2021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/5173035https://doaj.org/toc/1942-0994Cerebral ischemic stroke (IS) is still a difficult problem to be solved; energy metabolism failure is one of the main factors causing mitochondrion dysfunction and oxidation stress damage within the pathogenesis of cerebral ischemia, which produces considerable reactive oxygen species (ROS) and opens the blood-brain barrier. Dichloroacetic acid (DCA) can inhibit pyruvate dehydrogenase kinase (PDK). Moreover, DCA has been indicated with the capability of increasing mitochondrial pyruvate uptake and promoting oxidation of glucose in the course of glycolysis, thereby improving the activity of pyruvate dehydrogenase (PDH). As a result, pyruvate flow is promoted into the tricarboxylic acid cycle to expedite ATP production. DCA has a protective effect on IS and brain ischemia/reperfusion (I/R) injury, but the specific mechanism remains unclear. This study adopted a transient middle cerebral artery occlusion (MCAO) mouse model for simulating IS and I/R injury in mice. We investigated the mechanism by which DCA regulates glycolysis and protects the oxidative damage induced by I/R injury through the PDK2-PDH-Nrf2 axis. As indicated from the results of this study, DCA may improve glycolysis, reduce oxidative stress and neuronal death, damage the blood-brain barrier, and promote the recovery of oxidative metabolism through inhibiting PDK2 and activating PDH. Additionally, DCA noticeably elevated the neurological score and reduced the infarct volume, brain water content, and necrotic neurons. Moreover, as suggested from the results, DCA elevated the content of Nrf2 as well as HO-1, i.e., the downstream antioxidant proteins pertaining to Nrf2, while decreasing the damage of BBB and the degradation of tight junction proteins. To simulate the condition of hypoxia and ischemia in vitro, HBMEC cells received exposure to transient oxygen and glucose deprivation (OGD). The DCA treatment is capable of reducing the oxidative stress and blood-brain barrier of HBMEC cells after in vitro hypoxia and reperfusion (H/R). Furthermore, this study evidenced that HBMEC cells could exhibit higher susceptibility to H/R-induced oxidative stress after ML385 application, the specific inhibitor of Nrf2. Besides, the protection mediated by DCA disappeared after ML385 application. To sum up, as revealed from the mentioned results, DCA could exert the neuroprotective effect on oxidative stress and blood-brain barrier after brain I/R injury via PDK2-PDH-Nrf2 pathway activation. Accordingly, the PDK2-PDH-Nrf2 pathway may play a key role and provide a new pharmacology target in cerebral IS and I/R protection by DCA.Xiaoyong ZhaoShan LiYunchang MoRuru LiShaoyi HuangAnqi ZhangXuqing NiQinxue DaiJunlu WangHindawi LimitedarticleCytologyQH573-671ENOxidative Medicine and Cellular Longevity, Vol 2021 (2021)
institution DOAJ
collection DOAJ
language EN
topic Cytology
QH573-671
spellingShingle Cytology
QH573-671
Xiaoyong Zhao
Shan Li
Yunchang Mo
Ruru Li
Shaoyi Huang
Anqi Zhang
Xuqing Ni
Qinxue Dai
Junlu Wang
DCA Protects against Oxidation Injury Attributed to Cerebral Ischemia-Reperfusion by Regulating Glycolysis through PDK2-PDH-Nrf2 Axis
description Cerebral ischemic stroke (IS) is still a difficult problem to be solved; energy metabolism failure is one of the main factors causing mitochondrion dysfunction and oxidation stress damage within the pathogenesis of cerebral ischemia, which produces considerable reactive oxygen species (ROS) and opens the blood-brain barrier. Dichloroacetic acid (DCA) can inhibit pyruvate dehydrogenase kinase (PDK). Moreover, DCA has been indicated with the capability of increasing mitochondrial pyruvate uptake and promoting oxidation of glucose in the course of glycolysis, thereby improving the activity of pyruvate dehydrogenase (PDH). As a result, pyruvate flow is promoted into the tricarboxylic acid cycle to expedite ATP production. DCA has a protective effect on IS and brain ischemia/reperfusion (I/R) injury, but the specific mechanism remains unclear. This study adopted a transient middle cerebral artery occlusion (MCAO) mouse model for simulating IS and I/R injury in mice. We investigated the mechanism by which DCA regulates glycolysis and protects the oxidative damage induced by I/R injury through the PDK2-PDH-Nrf2 axis. As indicated from the results of this study, DCA may improve glycolysis, reduce oxidative stress and neuronal death, damage the blood-brain barrier, and promote the recovery of oxidative metabolism through inhibiting PDK2 and activating PDH. Additionally, DCA noticeably elevated the neurological score and reduced the infarct volume, brain water content, and necrotic neurons. Moreover, as suggested from the results, DCA elevated the content of Nrf2 as well as HO-1, i.e., the downstream antioxidant proteins pertaining to Nrf2, while decreasing the damage of BBB and the degradation of tight junction proteins. To simulate the condition of hypoxia and ischemia in vitro, HBMEC cells received exposure to transient oxygen and glucose deprivation (OGD). The DCA treatment is capable of reducing the oxidative stress and blood-brain barrier of HBMEC cells after in vitro hypoxia and reperfusion (H/R). Furthermore, this study evidenced that HBMEC cells could exhibit higher susceptibility to H/R-induced oxidative stress after ML385 application, the specific inhibitor of Nrf2. Besides, the protection mediated by DCA disappeared after ML385 application. To sum up, as revealed from the mentioned results, DCA could exert the neuroprotective effect on oxidative stress and blood-brain barrier after brain I/R injury via PDK2-PDH-Nrf2 pathway activation. Accordingly, the PDK2-PDH-Nrf2 pathway may play a key role and provide a new pharmacology target in cerebral IS and I/R protection by DCA.
format article
author Xiaoyong Zhao
Shan Li
Yunchang Mo
Ruru Li
Shaoyi Huang
Anqi Zhang
Xuqing Ni
Qinxue Dai
Junlu Wang
author_facet Xiaoyong Zhao
Shan Li
Yunchang Mo
Ruru Li
Shaoyi Huang
Anqi Zhang
Xuqing Ni
Qinxue Dai
Junlu Wang
author_sort Xiaoyong Zhao
title DCA Protects against Oxidation Injury Attributed to Cerebral Ischemia-Reperfusion by Regulating Glycolysis through PDK2-PDH-Nrf2 Axis
title_short DCA Protects against Oxidation Injury Attributed to Cerebral Ischemia-Reperfusion by Regulating Glycolysis through PDK2-PDH-Nrf2 Axis
title_full DCA Protects against Oxidation Injury Attributed to Cerebral Ischemia-Reperfusion by Regulating Glycolysis through PDK2-PDH-Nrf2 Axis
title_fullStr DCA Protects against Oxidation Injury Attributed to Cerebral Ischemia-Reperfusion by Regulating Glycolysis through PDK2-PDH-Nrf2 Axis
title_full_unstemmed DCA Protects against Oxidation Injury Attributed to Cerebral Ischemia-Reperfusion by Regulating Glycolysis through PDK2-PDH-Nrf2 Axis
title_sort dca protects against oxidation injury attributed to cerebral ischemia-reperfusion by regulating glycolysis through pdk2-pdh-nrf2 axis
publisher Hindawi Limited
publishDate 2021
url https://doaj.org/article/51f6dbe5bcbb4bb4b9e1225bc3d78e3e
work_keys_str_mv AT xiaoyongzhao dcaprotectsagainstoxidationinjuryattributedtocerebralischemiareperfusionbyregulatingglycolysisthroughpdk2pdhnrf2axis
AT shanli dcaprotectsagainstoxidationinjuryattributedtocerebralischemiareperfusionbyregulatingglycolysisthroughpdk2pdhnrf2axis
AT yunchangmo dcaprotectsagainstoxidationinjuryattributedtocerebralischemiareperfusionbyregulatingglycolysisthroughpdk2pdhnrf2axis
AT ruruli dcaprotectsagainstoxidationinjuryattributedtocerebralischemiareperfusionbyregulatingglycolysisthroughpdk2pdhnrf2axis
AT shaoyihuang dcaprotectsagainstoxidationinjuryattributedtocerebralischemiareperfusionbyregulatingglycolysisthroughpdk2pdhnrf2axis
AT anqizhang dcaprotectsagainstoxidationinjuryattributedtocerebralischemiareperfusionbyregulatingglycolysisthroughpdk2pdhnrf2axis
AT xuqingni dcaprotectsagainstoxidationinjuryattributedtocerebralischemiareperfusionbyregulatingglycolysisthroughpdk2pdhnrf2axis
AT qinxuedai dcaprotectsagainstoxidationinjuryattributedtocerebralischemiareperfusionbyregulatingglycolysisthroughpdk2pdhnrf2axis
AT junluwang dcaprotectsagainstoxidationinjuryattributedtocerebralischemiareperfusionbyregulatingglycolysisthroughpdk2pdhnrf2axis
_version_ 1718443094333980672